InvestorsHub Logo
Followers 165
Posts 19853
Boards Moderated 2
Alias Born 12/09/2004

Re: rx7171 post# 442661

Thursday, 12/14/2023 2:33:18 PM

Thursday, December 14, 2023 2:33:18 PM

Post# of 463368
Biogen may have thought that they could pick up the molecule cheap when Anavex went BK as so many developmental bio techs do.

Perhaps Missling wanted more for the drug access than Biogen was willing to pay, or they may not have thought 2-73 didn't have enough MS potential.

We won't have any insight into that unless Anavex runs a MS trial and we see how the results turn out.

"Wise men talk because they have something to say, fools because they have to say something."
PLATO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News